Scopia Capital Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-871,780
| Closed | -$29.5M | – | 24 |
|
|
2019
Q3 | $29.5M | Sell |
871,780
-111,225
| -11% | -$3.76M | 1.73% | 15 |
|
|
2019
Q2 | $44.2M | Sell |
983,005
-1,123,185
| -53% | -$50.5M | 1.96% | 15 |
|
|
2019
Q1 | $79.3M | Buy |
2,106,190
+479,225
| +29% | +$18M | 2.93% | 14 |
|
|
2018
Q4 | $55.8M | Buy |
1,626,965
+9,967
| +0.6% | +$342K | 1.89% | 18 |
|
|
2018
Q3 | $76M | Sell |
1,616,998
-686,343
| -30% | -$32.3M | 1.46% | 20 |
|
|
2018
Q2 | $77.7M | Sell |
2,303,341
-3,610,711
| -61% | -$122M | 1.36% | 24 |
|
|
2018
Q1 | $160M | Buy |
5,914,052
+1,770,782
| +43% | +$47.9M | 3.2% | 15 |
|
|
2017
Q4 | $69.1M | Buy |
4,143,270
+2,949,141
| +247% | +$49.2M | 1.24% | 23 |
|
|
2017
Q3 | $23.9M | Buy |
+1,194,129
| New | +$23.9M | 0.38% | 26 |
|